Currently, Coya Therapeutics Inc [COYA] is trading at $6.65, up 4.23%. An important factor to consider is whether the stock is rising or falling in short-term value. The COYA shares have gain 10.28% over the last week, with a monthly amount drifted -9.77%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
This stock has fluctuated between a low of $4.75 and a high of $10.69 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $18 within the next 12 months. Coya Therapeutics Inc [NASDAQ: COYA] shares were valued at $6.65 at the most recent close of the market. An investor can expect a potential return of 170.68% based on the average COYA price forecast.
Analyzing the COYA fundamentals
Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -1.17%, Pretax Profit Margin comes in at -1.04%, and Net Profit Margin reading is -1.12%. To continue investigating profitability, this company’s Return on Assets is posted at -0.3, Equity is -0.32 and Total Capital is -0.34.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.46 points at the first support level, and at 6.26 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.82, and for the 2nd resistance point, it is at 6.98.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Coya Therapeutics Inc [NASDAQ:COYA] is 15.31. On the other hand, the Quick Ratio is 15.31, and the Cash Ratio is 13.39. Considering the valuation of this stock, the price to sales ratio is 11.64, the price to book ratio is 3.16.
Transactions by insiders
Recent insider trading involved SNYDER DAVID S, Chief Financial Officer, that happened on Nov 14 ’24 when 1800.0 shares were purchased. Chief Executive Officer, Swaminathan Arun completed a deal on Nov 13 ’24 to buy 5000.0 shares. Meanwhile, Chief Medical Officer Grossman Fred bought 2710.0 shares on Nov 11 ’24.
